Deutsche Bank Starts National Health Investors (NHI) at Buy
Tweet
Share
E-mailGet Alerts NHI Hot Sheet
Price: $71.27 +0.76%
Rating Summary:
8 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
8 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Deutsche Bank analyst Omotayo Okusanya initiates coverage on National Health Investors (NYSE: NHI) with a Buy rating and a price target of $69.00.
For an analyst ratings summary and ratings history on National Health Investors click here. For more ratings news on National Health Investors click here.
Shares of National Health Investors closed at $54.57 yesterday.
You May Also Be Interested In
- National Health Investors (NHI) Tops Q2 EPS by 28c
- JPMorgan Starts SITC International Holdings Co Ltd (1308:HK) at Overweight
- Morgan Stanley Starts Achieve Life Sciences (ACHV) at Overweight
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
